StoneX Group’s T-REX 2X Inverse CRCL Daily Target ETF CRCD Stock Holding History

StoneX Group’s Portfolio CRCD Stock Details CRCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$135K	Buy	+20,000	New	+$548K	0.01%	774

Other funds holding CRCD

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

StoneX Group's CRCD Position: Q1 2026 in Review

StoneX Group opened a new position in T-REX 2X Inverse CRCL Daily Target ETF (CRCD) in Q1 2026: 20,000 shares worth $135K. The stake represents 0.01% of the portfolio and ranks #774 among its holdings.

8 funds tracked by Wall St. Rank hold CRCD as of Q1 2026.

StoneX Group held 20,000 shares of T-REX 2X Inverse CRCL Daily Target ETF worth $135K as of Q1 2026.
T-REX 2X Inverse CRCL Daily Target ETF was a new StoneX Group position in Q1 2026.
T-REX 2X Inverse CRCL Daily Target ETF made up 0.01% of StoneX Group's portfolio in Q1 2026, its #774 holding.
8 funds tracked by Wall St. Rank held T-REX 2X Inverse CRCL Daily Target ETF as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.